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Interdisciplinary care clinics in chronic
kidney disease
Tanya S. Johns1*, Jerry Yee2, Terrian Smith-Jules3, Ruth C. Campbell4 and Carolyn Bauer1
Abstract
The burden of chronic kidney disease (CKD) is substantial, and is associated with high hospitalization rates,
premature deaths, and considerable health care costs. These factors provide strong rationale for quality
improvement initiatives in CKD care. The interdisciplinary care clinic (IDC) has emerged as one solution to
improving CKD care. The IDC team may include other physicians, advanced practice providers, nurses,
dietitians, pharmacists, and social workers—all working together to provide effective care to patients with
chronic kidney disease. Studies suggest that IDCs may improve patient education and preparedness prior to
kidney failure, both of which have been associated with improved health outcomes. Interdisciplinary care may
also delay the progression to end-stage renal disease and reduce mortality. While most studies suggest that
IDC services are likely cost-effective, financing IDCs is challenging and many insurance providers do not pay for
all of the services. There are also no robust long-term studies demonstrating the cost-effectiveness of IDCs. This
review discusses IDC models and its potential impact on CKD care as well as some of the challenges that may
be associated with implementing these clinics.
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Background
Defining the need for interventions in the chronic kidney
disease population
Chronic kidney disease, defined as persistent albumin-
uria or glomerular filtration rate (GFR) <60 ml/min/
1.73 m2, affects ~12 % of the US population [1]. Individ-
uals with CKD are at increased risk for hospitalizations,
cardiovascular events, and mortality [2, 3]. The CKD
population is burdened with socioeconomic challenges
including high poverty rates [4] and low health literacy
[5], which contribute to poor outcomes [6, 7].
Areas for improvement in CKD care include patient
education, management of CKD risk factors, and com-
plications, and timely patient preparation for ESRD.
Nephrologists must also contend with a complex patient
population, increasing workload, and the pressure for
improved outcomes with a shrinking workforce that is
associated with fewer fellowship applicants [8]. These
issues have led to a critical appraisal of how CKD care is
being delivered and what outcomes should be followed
in health care systems. Interdisciplinary care clinic have
emerged as an alternative to traditional nephrology care
in response to many of these issues. Such clinics address
quality improvement, CKD management, and patient
education. Our intent is to discuss the potential role of
IDCs on improving CKD health outcomes in the United
States. We reviewed existing literature on CKD care in
PubMed using key words “interdisciplinary”, “multidis-
ciplinary”, or “coordinated” to find articles relevant to
the topic.
Review
Definition and domains of interdisciplinary care clinics
Interdisciplinary care is a coordinated, patient-centered
approach that integrates separate disciplines to achieve
common management goals [9]. Patients are empowered
to be part of the decision-making process, including the
setting of short- and long-term goals. There is no single
description of what constitutes an IDC in CKD, which at
a minimum should provide coordinated patient-centered
care that addresses meaningful CKD education and
effectively prepares patients for end-stage renal disease
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(ESRD). The KDIGO 2012 guidelines specify that interdis-
ciplinary nephrology care should encompass patient edu-
cation regarding different renal replacement therapy
(RRT) modalities and transplantation, dietary counseling,
early vascular access placement, and ethical, psychological
and social care [10] (Fig. 1). This approach to CKD care
often entails nephrologists and other health care providers
from different disciplines (e.g., other physicians, advanced
practice professionals (APP) formerly known as physician
extenders, pharmacists, social workers, and dietitians)
collaboratively implementing evidence-based guideline-
driven protocols in CKD care within the confines of the
patient’s (or proxy’s) expressed wishes (Table 1).
One of the most important domains of IDCs in CKD
care is to provide patient education. Despite decades
of awareness regarding the importance of patient educa-
tion and preparedness in improving health outcomes in
CKD [11, 12], national indicators demonstrate that predia-
lysis education is unacceptably low in the CKD population
and may not be optimal for maximizing dialysis prepared-
ness. For those patients that choose hemodialysis, one sur-
rogate of education and preparedness is the timely
placement of permanent dialysis vascular access. Almost
80 % of newly initiated hemodialysis (HD) patients begin
dialysis with a catheter [13]. Early referral to a nephrolo-
gist is necessary [14] but not sufficient for improving this
outcome parameter. A significant number of patients who
are followed by a nephrologist before initiating RRT will
still start with temporary vascular access; a lack of
education is likely a part of this phenomenon [15, 16].
Low health literacy has been shown to affect permanent
vascular access placement in ESRD patients [17].
Predialysis education is the most studied aspect of
IDC in nephrology. It is associated with increased selec-
tion of home HD and peritoneal dialysis (PD) modalities,
improved permanent access placement and reduced
mortality [17, 18]. Educational interventions offered for
only one day have been shown to have significant bene-
fits [11, 19]. In 2010, under the Medicare Improvement
of Patients and Providers Act (MIPPA), Medicare started
to reimburse for CKD education provided by a phys-
ician, APP, or clinical nurse specialist for Medicare
recipients with CKD stage 4 or 5. Up to six sessions of
education are reimbursed, and may be delivered either
as a class or on an individual basis in the outpatient
setting [20]. The classes may cover management of co-
morbidities, prevention of uremic complications, and
options for RRT (in-center HD, home therapies includ-
ing PD, access options and transplantation). A recent
survey of US nephrology practices found that only about
60 % offered a CKD education class and that an ad-
vanced practitioner delivered 87 % of the classes [21].
While CKD education is most commonly conducted in
the outpatient setting, education may also be delivered
effectively in the hospital. Rioux et al. described a pro-
gram of CKD education for hospitalized patients who
needed to start dialysis acutely. Their intervention, an
APP providing 3–5 inpatient sessions and a multimedia
Fig. 1 Domains of interdisciplinary chronic kidney disease care
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presentation, including handouts and DVDs, resulted in
31 % of patients choosing a home dialysis modality prior
to hospital discharge [22].
An important consideration in CKD education pro-
grams is the impact of health literacy. Low health liter-
acy, or how well a patient understands and assimilates
information to make decisions regarding his or her
health, is common in the US and among CKD patients
[23]. It is associated with increased mortality on dialysis
[7] and with lower referral rates for transplantation [24].
These data suggest that both education and assessment
of patients’ understanding of their disease and potential
treatments are essential to provide the most effective
CKD care.
Another important domain of IDCs is establishment
of patient-centered goals of care. This is particularly im-
portant among high-risk groups. Among the elderly, for
example, the high risk of mortality and decreased func-
tional status associated with ESRD [25, 26] warrants ad-
vanced care planning as part of the services provided by
IDCs. In the US, 20 % of patients who died in the initial
120 days after starting dialysis stopped treatment [27].
Planning ahead and clarifying patients’ wishes prior to
ESRD may decrease aggressive and costly measures. An
elderly patient may choose a time-trial of dialysis with
specific withdrawal parameters. Geriatric-palliative care
physicians, as part of the interdisciplinary care team,
may assess patients’ functional and decision-making cap-
acities and help determine and communicate overall
prognosis for the elderly. The social workers in the team
could assist with supplying resources, the completion of
health care proxy and advanced directives (Table 1). For
patients who decide on less aggressive medical man-
agement of their stage 5 CKD—the “no dialysis”
option—IDC programs should continue to provide ser-
vices that facilitate patient overall wellness and comfort.
Goals of interdisciplinary care clinics
The ultimate goals of IDCs are to improve morbidity
and mortality for patients with CKD. To achieve these
goals, IDCs will need to focus on managing cardiovas-
cular risks, implement practices to retard the progres-
sion of CKD, and transition patients safely from CKD
to ESRD. Other common goals of IDCs are to identify
and manage the complications of CKD such as hyper-
tension, anemia, mineral and bone disorders, electrolyte
disturbances and fluid imbalances according to guide-
lines established by Kidney Disease Quality Initiative
Outcomes (KDIGO) [10, 28]. IDCs may also support
vaccination against influenza, Streptococcus pneumo-
niae, and hepatitis B given the immunosuppressive
nature of CKD [29, 30].
IDC in improving morbidity and mortality
Traditional risk factors for CVD such as increasing age,
hypertension, diabetes, and hyperlipidemia are highly
prevalent in the CKD population [31]. Lipid-lowering
therapies in CKD patients have been shown to improve
cardiovascular outcomes [32, 33]. Other nontraditional
risk factors for CVD have been identified in patients
with CKD, including albuminuria, anemia, fluid over-
load, vascular calcification, inflammation, malnutrition,
and increased oxidative stress [34–37]. Dietitians, with
renal-specific training, in an IDC model should work
with patients to prevent, diagnose, and address malnutri-
tion. Smoking is associated with CVD and observational
data suggest that smoking may influence the progression
of renal disease, and therefore, smoking cessation should
to be addressed in CKD patient [38, 39].
IDC in slowing CKD progression
CKD clinics should strongly advocate for the use inter-
ventions that slow the decline of renal function as
Table 1 Potential roles for an interdisciplinary care clinic in CKD (modeled on montefiore medical center kidney care program)
Nephrologist Evaluates etiology of CKD and determines the care plan
Advanced practitioner Educates about CKD and kidney failure treatment options
Coordinates care with family and members of the IDC team
Dietitian Dietary counseling and fluid management
Pharmacist Reviews medications, dosing, and adherence
Educates patients about the use of over the counter medications and herbal preparations
Geriatrician/palliative care Addresses geriatric and palliative care needs
Discusses prognosis and ensures treatment plans align with goal of care
Case management/social work Assists patients to obtain needed resources (e.g., transportation and issues with housing)
Transplant team Educates patients about transplant options
Evaluates potential transplant candidates with progressive CKD
Vascular surgery/general surgery Places and monitors access for dialysis (hemodialysis and peritoneal dialysis)
Interventional radiology Intervenes on immature or nonfunctioning AVG/AVF to improve access flow in order to initiate dialysis
IDC interdisciplinary care clinic, AVG arteriovenous graft, AVF arteriovenous fistula
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feasible. Unfortunately, very few interventions have
been shown to slow progression of CKD. Control of
hypertension, especially with angiotensin converting
enzyme inhibitors or angiotensin receptor blockers in
diabetics and non-diabetics with proteinuria could
delay the progression of CKD [40–44] and reduce
cardiovascular events [45]. Other interventions that
may slow progression of kidney disease include the
treatment of metabolic acidosis, avoiding nephrotox-
ins (e.g., nonsteroidal anti-inflammatory drugs) and
effective patient education [46, 47]. Pharmacists in an
IDC may work in concert with nephrologists to en-
sure patient medication adherence, and to determine
inappropriate medications that should be discontinued
or medications that need to be re-dosed to patients’
GFRs. Education also plays a role in delaying ESRD. One
randomized study of advanced CKD patients revealed that
a single education session with nurse follow-up was asso-
ciated with delay in the initiation of RRT by approximately
3 months [48].
IDC in transitioning patients from CKD to ESRD
Another important goal of IDCs is to safely and effect-
ively transition patients with advancing CKD to ESRD
care. In particular, the IDC should aim to lower the high
morbidity and mortality associated with the commence-
ment of dialysis [13, 49]. A planned transition to dialysis
should result in improved health and reduced costs for
patients. The IDC team should help to create patient-
centered action plans for initiating dialysis, coordinate
listing for kidney transplantation, and define goals of
care for patients who may not desire or benefit from
these modalities. Education, in individual or group ses-
sions, regarding RRT is paramount to this process.
Patients (and their families) must understand the differ-
ent options RRT (PD, in-center and home HD, and
transplantation) to facilitate informed decision-making
that best accommodates patients’ desires and circum-
stances. A discussion of an individual’s prognosis and
the risks and benefits of dialysis and transplantation
should be provided to each patient. Preparation for dia-
lysis should occur simultaneously with evaluation for
transplantation. Ideally, the modality for RRT should be
established at least 6 months to 1 year prior to the devel-
opment of ESRD to allow for timely access placement and
the work-up required prior to transplantation. Patients be-
ginning dialysis via a HD catheter have a significantly in-
creased risk of death compared to patients who began
dialysis with an arteriovenous fistula (AVF) [50, 51]. Part-
nership with a vascular surgeon with high-level expertise
in AVFs and arteriovenous grafts (AVGs) construction
would ensure consistent establishment of functioning
AVFs in suitable individuals. As starting HD in the hos-
pital is costly, interdisciplinary CKD programs should aim
to facilitate outpatient dialysis starts in appropriate pa-
tients. Patients should be given options to choose home
modalities (such as PD and home HD) because these mo-
dalities preserve independence and quality of life better
than in-center hemodialysis and are less costly. Trans-
plantation prior to starting RRT is associated with
improved patient and kidney allograft survival [52–54].
The IDC may coordinate with a transplant center to en-
sure timely referrals to transplantation, transplantation
education, and discussions between patients and their
families regarding live kidney donation.
Models of IDCs and barriers to interdisciplinary care
The most common IDC structure is to have interdis-
ciplinary services provided by the nephrology practice.
Instead of being embedded in the practice, some
IDCs may run in parallel to a nephrology practice,
with patients alternating between IDC visits and gen-
eral nephrology visits. In this model, it is imperative
that the IDC and nephrologist work in unison as a
team and not as competing providers. Another struc-
tural component to consider is who is referring the
patients to the IDC. Some IDCs may incorporate a
nephrology evaluation as part of their services and
take referrals directly from primary care physicians
(PCPs) [55], while other clinics may offer only educa-
tion or protocol driven management of CKD and not
accept a referral from a PCP. This illustrates the im-
portance of clearly defining the role of the IDC in re-
lation to both nephrology and primary care.
Financial constraints of the providers and patients may
limit the ability to offer all services to patients. As such,
nephrology practices may seek to identify and prioritize
the services that are needed the most by their constitu-
ent populations to improve health outcomes. In order to
achieve this, the CKD clinic team may implement qual-
ity improvement processes to monitor outcomes and
maximize patient benefits. Patient-level barriers such as
education attained, health literacy, family support, and
psychosocial and cultural beliefs may also affect the im-
plementation and effectiveness of IDCs. The additional
time spent in IDCs and potential additional cost in-
curred by patients in travel may overwhelm some and
could adversely impact patient engagement. Overcoming
some of these barriers may necessitate intensive case
management and are potentially costly.
Economics of interdisciplinary care clinics
Each IDC is setup differently and influenced by variables
such as budgeting and office space. Funding for IDCs
may vary greatly in different countries depending on the
resources of the national health care system and the ex-
tent of health care privatization. In the United States,
APPs can bill most insurance companies directly, but
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the standard fee-for-service model may not reimburse
some of the other team members. Renal dietitians are re-
imbursed by Medicare for stage 4 CKD patients, but
other insurance companies may not cover their services.
A social worker is reimbursed for services only when
providing counseling for a Diagnostic and Statistical
Manual of Mental Disorders (DSM)-5 diagnosis.
Pharmacist services are not reimbursable. These finan-
cial constraints may make it difficult for nephrologists to
provide an IDC model of CKD to their patients. Grants,
awards, donations, or alternative sources of funding may
be required, which could limit IDCs in the US to large
academic institutions. The creation of accountable care
organizations (ACOs), which are groups of health care
providers that assume responsibility for the quality, cost-
effectiveness, and general health care of specified US
Medicare beneficiaries, may represent an important
source of funding for these IDC initiatives in the future.
Increased outpatient dialysis starts and greater AVF
and PD selection rates may help persuade funding
sources that CKD clinics are cost-effective and sustain-
able. In 2007, the average inpatient cost for the first
month of dialysis in the U.S. was $9,846 per Medicare
member and $22,841 per employer group health plan
member [56]. These costs could be greatly reduced by
increasing outpatient dialysis starts. Patients with AVFs
compared to those with HD catheters had a lower total
per member per year cost at $64,701 and $90,110, re-
spectively [56]. Increasing rates of PD as the initial mo-
dality for ESRD is also cost-effective. According to the
United States Renal Data System database, the total
yearly expenditures per patient in 2010 for HD was
$87,561 compared to $66,751 for PD, a savings of over
$20,000 per patient per year [13]. Overall, the cost sav-
ings to be gained through an improved transition to
ESRD likely outweigh the greater costs of an IDC team.
Target population for interdisciplinary care clinics
Patients at the highest risk for progression to ESRD or
patients who have complications of CKD that need spe-
cialized management (e.g., anemia and mineral bone dis-
orders) are logical populations to target. The 2012
KDIGO CKD guidelines suggest that patients with pro-
gressive CKD be treated in an IDC setting, but the
guidelines do not specify a GFR cutoff [28]. Therefore,
identification of patients at greatest risk is necessary. A
number of validated prediction models have been devel-
oped to help estimate the risk of progression to ESRD
[57]. Tangri et al. developed a prediction model that uses
age, sex, estimated glomerular filtration rate (eGFR),
urine albumin-to-creatinine ratio, calcium, phosphorus,
albumin and bicarbonate to predict risk of progression
[58], which is also available as a software application for
smart devices (http://www.qxmd.com/specialty/medicine/
nephrology-medical-apps-iphone-blackberry-android).
More recently, Maziarz et al. showed that among the urban
poor, a prediction model using five common variables (age,
sex, race, eGFR, and dipstick proteinuria) performed simi-
larly to more complex models that incorporated extensive
sociodemographic and clinical data [59].
Clinical outcomes of interdisclipinary clinics in chronic
kidney disease care
While the variety of structures makes it difficult to study
outcomes and efficacy of IDCs in CKD care, the litera-
ture does suggest that these programs improve AV ac-
cess placement before initiation of RRT, reduce mortality
rates during the transition from CKD to ESRD, slow
progression of CKD, and are likely cost-effective.
One study by Snyder and Collins found that a higher
number of preventive measures including monitoring
lipids, glucose control, and mineral and bone parameters
as well as influenza vaccination were associated with low
rates of atherosclerotic heart disease in a Medicare CKD
cohort [60]. In a Canadian province, Hemmelgarn et al.
demonstrated a 50 % reduction in risk of death in a
predialysis cohort who received interdisciplinary care
compared with a propensity-matched control group who
had usual nephrology care (Table 1) [61]. A prospective
cohort study in Taiwan also demonstrated decreased
mortality for those patients who underwent IDC care
[62]. Two other cohort studies supported that exposure
to IDC care decreased mortality rates after dialysis initi-
ation [12, 63]. Fresenius Medical Care North America, a
large dialysis organization, established that patients who
underwent a predialysis educational program were sig-
nificantly more likely to choose PD as their RRT modal-
ity, begin HD with an AVF or AVG, and less likely to die
within the first 90 days following onset of dialysis [64].
The Multifactorial Approach and Superior Treatment
Efficacy in Renal Patients with the Aid of Nurse Practi-
tioners (MASTERPLAN), a randomized trial of 788
Dutch patients, showed that the additional implementa-
tion of current CKD guidelines by APPs in CKD stage 3
and 4 patients compared to usual nephrology care
slowed their rates of decline of eGFR. Also, the risk of
developing the composite end-point of death, ESRD and
a 50 % increase in serum creatinine over a median
follow-up of six years was reduced [65]. The previously
published MASTERPLAN trial at a median follow-up of
5 years did not reveal a significant difference in CVD
outcomes but showed that APP supported care de-
creased CVD risk factors (high blood pressure, LDL
cholesterol, anemia, and proteinuria) [66] (Table 2). The
generalizability of this study may be limited by the inclu-
sion of a relatively young and “healthy” CKD patient
population. Although the study was not designed to
evaluate the cost-effectiveness of the intervention, the
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Table 2 Studies Comparing Interdisciplinary Care Models to Standard Nephrology Care for Mortality, Hospitalizations and Renal Outcomes
Study, year Study population and design Exposure or intervention Outcomes Major findings Cost-benefit
Curtis et al.,
2003 [63]
Retrospective cohort study of 288
incident dialysis patients (mean age
62 years) in Canada and Italy
Formalized multidisciplinary clinic
programs consisting of a nurse educator,
physician, social worker, nutritionist, and
pharmacist
Mortality up to 2.5 years
after dialysis initiation
HR 0.46 (95 % CI 0.23–0.90) for
IDC group after adjustments for
age, sex, calculated GFR at
dialysis start, race, diabetes,
etiology of kidney failure, and
country of treatment
Not assessed
Goldstein et al.,
2004 [12]
Retrospective cohort study of 184
Canadian incident dialysis patients
(mean age 60 years)
Progressive multidisciplinary renal disease
clinic that included a dietitian, nurse
educator, pharmacist, social worker and
volunteer peer supporters
Mortality and
hospitalizations at
1 year after starting
dialysis
Fewer deaths in the IDC group
(2 % versus 23 %; P < 0.01) and
fewer hospitalizations (7 versus
69.7 days/patient/year (P < 0.01)
Not assessed
Independent predictors of death
were older age, history of
cardiovascular disease and
non-IDC.
Hemmelgarn et al.,
2009 [61]
Propensity score matched cohort
study of 6978 elderly Canadian
patients (mean age 76 years) with
CKD stage 4 and 5
Multidisciplinary care clinic utilizing
nurses, dietitians and social workers
1. Mortality2. All-cause
and cardiovascular-
specific hospitalizations
HR 0.50 (95 % CI 0.35–0.71) for
the IDC group after adjustments
for age, gender, baseline GFR,
diabetes, and comorbidity score
in the MDC group compared to
standard groupNo difference in
all-cause (HR 0.83; 95 % CI 0.64–
1.06) or cardiovascular-specific
hospitalization (HR 0.76; 95 %
CI 0.54 to 1.06) adjusted for age,
gender, baseline GFR, diabetes,
and comorbidity score
Not assessed
Wu et al.,
2009 [62]
Prospective cohort study of 573
Taiwanese patients (mean age 63
years) with GFR <60 ml/min/1.73 m2
Multidisciplinary care with nurses for case
management, dietitians, volunteer peer
supporters
1. Progression to ESRD HR 0.117 (95 % CI 0.075–0.183)
for the IDC group after adjustments
for age, gender, DM and HTN
status, baseline eGFR, hemoglobin
and albumin
Not assessed
2. All-cause mortality HR 0.10 (95 % CI 0.04–0.265) for
the IDC group after adjustments
for gender, DM and HTN status,
baseline eGFR, hemoglobin and
albumin
Wei et al.,
2010 [71]
Cohort study of 137 Taiwanese
patients (mean age 57 control group
and 63 exposed group) with CKD
stage 3–5
Multidisciplinary team including renal
nurses and dieticians
Hospitalization for
hemodialysis initiation
40.8 % in the intervention group
were not hospitalized compared
to 18.8 % in the usual care group
(P < 0.005)
Favored intervention
Lacson et al.,
2010 [64]
Matched (1:1) study of 2,800 incident
dialysis (mean age 63 years) in the
United States
Educational program on treatment
options for dialysis
Mortality within the
first 90 days of starting
dialysis
HR 0.61 (95 % CI 0.50–0.74) for
treatment options attendees
compared to usual care after
adjustments for case-mix and
laboratory data
Not assessed
Rate of decline in GFR Not assessed
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Table 2 Studies Comparing Interdisciplinary Care Models to Standard Nephrology Care for Mortality, Hospitalizations and Renal Outcomes (Continued)
Barrett et al., 2011
[69] CanPREVENT
Randomized control trial of 474
patients (mean age 67 years) with
CKD stage 3 and 4 in Canada
Nurse-coordinated care focused on risk
factor modification
Nurse-coordinated team did
not alter rate of GFR decline
Baylis et al.,
2011 [68]
Cohort study of 2002 patients
(mean age 68 years) with CKD
stage 3 in the United States
Multidisciplinary team consisting of
nephrologist, renal clinical pharmacy
specialist, diabetes nurse educator,
renal dietitian, social worker, and
nephrology nurse
Rate of decline in GFR Mean annual decline in GFR
1.73 ml/min/1.73 m2 in the
intervention group compared to
2.1 ml/min/1.73 m2 in the usual
care group after adjustments for
nephrology site, follow-up time,
race, age, baseline GFR, gender,
number of chronic conditions,
body mass index, number of GFR
measurements, and number of
primary care visit (P < 0.0001)
Not assessed
Devins et al.,
2011 [48]
Multi-center randomized control
trial of 323 Canadian patients (mean
age 54 years) with progressive CKD
(deemed likely start dialysis in next
6 to 12 months)
Predialysis psychoeducation Time to dialysis initiation Median time to dialysis was
17.0 months in the intervention
group compared to 14. 2 months
in usual-care control group
(P < 0.001)
Not assessed
Van Zullen et al.,
2012 [66] MASTERPLAN
Randomized control trial of 788 patients
(mean age 59 years) from the
Netherlands with CKD stage 3 and 4
Addition of nurse practitioner
coordinated care
1. Composite of myocardial
infarction, stroke, or
cardiovascular death.
No difference (HR 0.90; 95 %
CI 0.58–1.39)
2. Composite vascular
interventions, all-cause
mortality or end-stage
renal disease
No difference (HR 0.83; 95 %
CI 0.57–1.20)
Peeters et al., 2014
[65] MASTERPLAN
1. Composite of incident
ESRD, death, or 50 %
increase in creatinine
HR 0.80 (95 % CI 0.66–0.98)
in the intervention group vs.
control
Crude estimate of
savings and costs
favored intervention
2. Difference in slope
of GFR
Decrease in estimated GFR was
0.45 ml/min per 1.73 m2 per year
less in intervention group vs.
control (P = 0.01)
HR hazard ratio, CI confidence interval, IDC interdisciplinary care clinic
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authors reported a crude estimate of savings and costs,
implying cost benefits of the MASTERPLAN study [65].
Similar to MASTERPLAN [65], other studies have also
shown that IDC services may slow progression of CKD.
A randomized trial demonstrated that a single 90-min
education session along with follow-up phone calls sig-
nificantly delayed dialysis initiation by approximately
3 months in patients expected to start dialysis within
6–18 months [48]. A program in England determined
that patients with eGFRs less than 30 ml/min/
1.73 m2who had access to a nurse, patient education,
medication management, and nutrition counseling had a
decreased rate of eGFR decline, with the greatest benefit
to those patients with rapidly progressive CKD [67].
In early CKD and non-progressive CKD, there is con-
flicting data on the efficacy of IDC care. In a large health
maintenance organization population, a study found a
slower eGFR decline in those patients who were enrolled
in IDCs compared with historical controls [68]. The
Canadian Prevention of Renal and Cardiovascular End-
points Trial (CanPREVENT) did not show that nurse-
coordinated care improved the rate of GFR decline or
control of most risk factors compared with usual care in
patients with largely non-progressive kidney disease [69].
However, nurse-coordinated care entailed several benefits
including fewer visits to specialists such as cardiologists
and fewer days in hospital [69]. Therefore, nurse-
coordinated care following stratification of CKD by stage
as well as type may offer a cost-effective solution to the
overall cost of health care.
The literature on interdisclipinary care services has
more consistently demonstrated the increased use of
arteriovenous accesses at HD initiation and decreased
hospitalization rates. Cohort studies performed in
California, Taiwan, and Canada demonstrated that pa-
tients exposed to IDC care had significantly decreased
hospitalizations and more AVFs [19, 70, 71]. One
single-center study revealed that guideline-driven care
by APPs was associated with improved functioning,
permanent vascular accesses and decreased hospitali-
zations 12 months after dialysis initiation [72].
Conclusion
Interdisclipinary care clinics in CKD care are associated
with greater patient preparedness and improved health
outcomes during the transition from CKD to ESRD, espe-
cially among patients at increased risk for CKD progres-
sion based on risk of ESRD prediction, sociodemographic
factors, eGFR level, and rate of decline of eGFR. While dif-
ferent models for IDC in CKD care exist, the goal should
be to include those interventions with demonstrated suc-
cess within the limitations of available resources. Although
IDCs appear promising in CKD care, studies with longer
follow-up and higher risk patients are required to better
understand the quality and utility of IDCs. Funding for
IDC services may be challenging despite the potential cost
savings of such clinics. Therefore, robust studies regarding
the cost-effectiveness of IDCs should be pursued, planned
and performed.
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